The announcement indicates that MMX have cross claimed against two of their co-defendents in relation to the transactions that CHM claim is based upon.
This seems to indicate that at least part of the claim must have some "foundation" if MMX are now suing their ex directors.
Interesting times
- Forums
- ASX - By Stock
- CHM
- latest chm announcement
CHM
chimeric therapeutics limited
Add to My Watchlist
11.1%
!
0.5¢

latest chm announcement
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $10.07M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.4¢ | $36.69K | 7.556M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 22352035 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 14512739 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 20602035 | 0.004 |
38 | 27574272 | 0.003 |
18 | 15950508 | 0.002 |
12 | 54150000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 14012739 | 13 |
0.006 | 9198729 | 10 |
0.007 | 3100000 | 2 |
0.008 | 8685291 | 7 |
0.009 | 1037990 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online